DrugPatentWatch Database Preview
Details for Patent: 6,376,515
Which drugs does patent 6,376,515 protect, and when does it expire?
Patent 6,376,515 protects BEVYXXA and is included in one NDA.
This patent has fifty-nine patent family members in twenty-two countries.
Summary for Patent: 6,376,515
| Title: | Benzamides and related inhibitors of factor Xa |
| Abstract: | Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders. |
| Inventor(s): | Zhu; Bing-Yan (Belmont, CA), Zhang; Penglie (Foster City, CA), Wang; Lingyan (Chatham, NJ), Huang; Wenrong (Cupertino, CA), Goldman; Erick A. (San Francisco, CA), Li; Wenhao (South San Francisco, CA), Zuckett; Jingmei (Glendale, AZ), Song; Yonghong (Foster City, CA), Scarborough; Robert M. (Half Moon Bay, CA) |
| Assignee: | COR Therapeutics, Inc. (South San Francisco, CA) |
| Application Number: | 09/794,225 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Compound; Device; |
Drugs Protected by US Patent 6,376,515
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-001 | Jun 23, 2017 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | Y | PROPHYLAXIS OF VENOUS THROMBOSIS | ➤ Sign Up | ||
| Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-001 | Jun 23, 2017 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | Y | PROPHYLAXIS OF PULMONARY EMBOLISM | ➤ Sign Up | ||
| Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-001 | Jun 23, 2017 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | Y | PROPHYLAXIS OF DEEP VEIN THROMBOSIS (DVT) | ➤ Sign Up | ||
| Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-001 | Jun 23, 2017 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | Y | PREVENTING CONDITION CHARACTERIZED BY UNDESIRED THROMBOSIS | ➤ Sign Up | ||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
International Family Members for US Patent 6,376,515
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 311366 | ➤ Sign Up | |||
| Austria | 412629 | ➤ Sign Up | |||
| Australia | 4535301 | ➤ Sign Up | |||
| Australia | 5078301 | ➤ Sign Up | |||
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
